CENTRE HOSPITALIER REGIONAL UNIVERSITAIRE ;INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE);CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE;UNIVERSITE DU DROIT ET DE LA SANTE DE LILLE 2
发明人:
MONIQUE CAPRON,MOHAMED EL NADY,JEAN-FREDERIC COLOMBEL,GILLES RIVEAU
申请号:
FR1251100
公开号:
FR2986432B1
申请日:
2012.02.06
申请国别(地区):
FR
年份:
2014
代理人:
摘要:
The present invention relates to a product selected from a protein, a fragment of the protein, a derived sequence and a homologous sequence of the protein, the protein including or being constituted by the 28 kDa glutathione S-transferase protein from a schistosome selected from Schistosoma haematobium, Schistosoma mansoni, Schistosoma bovis represented respectively by the sequences SEQ ID NO: 1, SEQ ID NO: 2 and SEQ ID NO: 3 for the use thereof in the treatment of an inflammatory autoimmune disease generating a response of type Th1 and/or Th17.